TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Scandbio AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2022/04 (consolidated) |
Turnover |
1,110,150
|
619,468
|
922,781 |
Financial expenses |
39
|
226
|
1,652 |
Earnings before taxes |
197,181
|
139,114
|
70,673 |
EBITDA |
209,818
|
150,792
|
95,500 |
Total assets |
600,345
|
623,918
|
541,951 |
Current assets |
418,881
|
451,233
|
366,658 |
Current liabilities |
293,608
|
201,122
|
168,962 |
Equity capital |
293,616
|
410,786
|
359,384 |
- share capital |
6,000
![]() |
6,000
![]() |
6,000 |
Employees (average) |
103
|
106
|
130 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2022/04 (consolidated) |
Solvency |
48.9%
|
65.8%
|
66.3% |
Turnover per employee |
10,778
|
5,844
|
7,098 |
Profit as a percentage of turnover |
17.8%
|
22.5%
|
7.7% |
Return on assets (ROA) |
32.9%
|
22.3%
|
13.3% |
Current ratio |
142.7%
|
224.4%
|
217.0% |
Return on equity (ROE) |
67.2%
|
33.9%
|
19.7% |
Change turnover |
490,682
|
-303,313
|
16,457 |
Change turnover % | 79% | 2% | |
Chg. No. of employees |
-3
|
-24
|
-9 |
Chg. No. of employees % | -3% | -6% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2022/04 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.